guest ::
| Home > Publications database > HLA matching or CRISPR editing of HLA class I/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model. |
| Home > Publications database > HLA matching or CRISPR editing of HLA class I/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model. |
| Journal Article | DKFZ-2025-02104 |
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
2025
Springer Nature
[London]
This record in other databases: 
Please use a persistent id in citations: doi:10.1038/s41467-025-64945-3
Abstract: Regulatory T cells (Tregs) hold promise for treating autoimmune disease and transplant rejection, yet generation of autologous products for adoptive transfer can suffer donor variability and slow turnaround, limiting their use in urgent indications. We therefore examine whether allogeneic, pre-manufactured ('off-the-shelf') Tregs could overcome these barriers. In a human skin-xenograft model, HLA-mismatched Tregs are swiftly eliminated by recipient CD8+ T cells and fail to protect grafts. Stringent matching of HLA class I and II restores efficacy but is clinically impractical. Using non-viral CRISPR editing we disrupt B2M and CIITA while inserting an HLA-E-B2M fusion, generating hypo-immunogenic Tregs that evade both T and NK cell attack. Engineered cells retain FOXP3 stability and potent in vitro suppression, and after a single low-dose infusion, prolong human skin graft survival in a humanized mouse model comparably to autologous Tregs. Histology and spatial transcriptomics reveal minimal cytotoxic infiltration and enrichment of immunoregulatory and tissue-repair programmes. Multiplex HLA engineering thus enables ready-to-use allogeneic Tregs that withstand host immune attack for adoptive transfer.
Keyword(s): Animals (MeSH) ; Humans (MeSH) ; T-Lymphocytes, Regulatory: immunology (MeSH) ; T-Lymphocytes, Regulatory: transplantation (MeSH) ; Mice (MeSH) ; Skin Transplantation (MeSH) ; Gene Editing: methods (MeSH) ; Graft Survival: immunology (MeSH) ; CRISPR-Cas Systems (MeSH) ; Transplantation, Homologous (MeSH) ; Histocompatibility Antigens Class I: genetics (MeSH) ; Histocompatibility Antigens Class I: immunology (MeSH) ; Adoptive Transfer (MeSH) ; Forkhead Transcription Factors: metabolism (MeSH) ; Forkhead Transcription Factors: genetics (MeSH) ; CD8-Positive T-Lymphocytes: immunology (MeSH) ; Histocompatibility Antigens Class I ; Forkhead Transcription Factors
; 
; 
; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Agriculture, Biology and Environmental Sciences ; Current Contents - Life Sciences ; Current Contents - Physical, Chemical and Earth Sciences ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 15 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection ; Zoological Record
|
The record appears in these collections: |
